PRRX1 upregulates PD-L1 in human mesenchymal stem cells

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: PRRX1 upregulates PD-L1 in human mesenchymal stem cells ; day:25 ; month:4 ; year:2024 ; pages:1-6
In vitro cellular & developmental biology / Animal. Animal ; (25.4.2024), 1-6

Creator: Osawa, Taro
Yamada, Daisuke
Takao, Tomoko
Ming, Lu
Takarada, Takeshi

Contributor: SpringerLink (Online service)

DOI: 10.1007/s11626-024-00911-5

URN: urn:nbn:de:101:1-2407120717472.424091833880

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:02 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Osawa, Taro
Yamada, Daisuke
Takao, Tomoko
Ming, Lu
Takarada, Takeshi
SpringerLink (Online service)

Other Objects (12)

Transmural Flow Upregulates PD‐L1 Expression in Microvascular Networks

RelB upregulates PD-L1 and exacerbates prostate cancer immune evasion

5-Fluorouracil upregulates cell surface B7-H1 (PD-L1) expression in gastrointestinal cancers

TIMELESS upregulates PD-L1 expression and exerts an immunosuppressive role in breast cancer

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

IL-17A promotes tumorigenesis and upregulates PD-L1 expression in non-small cell lung cancer

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Hsp90 up-regulates PD-L1 to promote HPV-positive cervical cancer via HER2/PI3K/AKT pathway

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Regulatory mechanisms of PD-1/PD-L1 in cancers

Transmural Flow Upregulates PD‐L1 Expression in Microvascular Networks

RelB upregulates PD-L1 and exacerbates prostate cancer immune evasion

5-Fluorouracil upregulates cell surface B7-H1 (PD-L1) expression in gastrointestinal cancers

TIMELESS upregulates PD-L1 expression and exerts an immunosuppressive role in breast cancer

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

IL-17A promotes tumorigenesis and upregulates PD-L1 expression in non-small cell lung cancer

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Hsp90 up-regulates PD-L1 to promote HPV-positive cervical cancer via HER2/PI3K/AKT pathway

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Regulatory mechanisms of PD-1/PD-L1 in cancers

Transmural Flow Upregulates PD‐L1 Expression in Microvascular Networks

RelB upregulates PD-L1 and exacerbates prostate cancer immune evasion

5-Fluorouracil upregulates cell surface B7-H1 (PD-L1) expression in gastrointestinal cancers

TIMELESS upregulates PD-L1 expression and exerts an immunosuppressive role in breast cancer

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

IL-17A promotes tumorigenesis and upregulates PD-L1 expression in non-small cell lung cancer

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Hsp90 up-regulates PD-L1 to promote HPV-positive cervical cancer via HER2/PI3K/AKT pathway

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Regulatory mechanisms of PD-1/PD-L1 in cancers

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

PRRX1 upregulates PD-L1 in human mesenchymal stem cells

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Transmural Flow Upregulates PD‐L1 Expression in Microvascular Networks

RelB upregulates PD-L1 and exacerbates prostate cancer immune evasion

5-Fluorouracil upregulates cell surface B7-H1 (PD-L1) expression in gastrointestinal cancers

TIMELESS upregulates PD-L1 expression and exerts an immunosuppressive role in breast cancer

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

IL-17A promotes tumorigenesis and upregulates PD-L1 expression in non-small cell lung cancer

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Hsp90 up-regulates PD-L1 to promote HPV-positive cervical cancer via HER2/PI3K/AKT pathway

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Regulatory mechanisms of PD-1/PD-L1 in cancers

Transmural Flow Upregulates PD‐L1 Expression in Microvascular Networks

RelB upregulates PD-L1 and exacerbates prostate cancer immune evasion

5-Fluorouracil upregulates cell surface B7-H1 (PD-L1) expression in gastrointestinal cancers

TIMELESS upregulates PD-L1 expression and exerts an immunosuppressive role in breast cancer

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

IL-17A promotes tumorigenesis and upregulates PD-L1 expression in non-small cell lung cancer

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Hsp90 up-regulates PD-L1 to promote HPV-positive cervical cancer via HER2/PI3K/AKT pathway

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Regulatory mechanisms of PD-1/PD-L1 in cancers

Transmural Flow Upregulates PD‐L1 Expression in Microvascular Networks

RelB upregulates PD-L1 and exacerbates prostate cancer immune evasion

5-Fluorouracil upregulates cell surface B7-H1 (PD-L1) expression in gastrointestinal cancers

TIMELESS upregulates PD-L1 expression and exerts an immunosuppressive role in breast cancer

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

IL-17A promotes tumorigenesis and upregulates PD-L1 expression in non-small cell lung cancer

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Hsp90 up-regulates PD-L1 to promote HPV-positive cervical cancer via HER2/PI3K/AKT pathway

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Regulatory mechanisms of PD-1/PD-L1 in cancers

Related objects

Reset password